Global latex tourniquet market forecast at $815.2 million by 2029

Bedfordshire, UK – The Global Latex Tourniquet Market is expected to reach $815.2 Million at a CAGR of 7.5% during the forecast period 2022-2029 according to Exactitude Consultancy.

A Latex Tourniquet is a tool for compressing or restricting. It is utilized to short-term restrict venous and arterial blood flow to a portion of an extremity. It is tied around a portion of the limb at a specific location so that pressure is given to the blood vessel walls. They consequently briefly restrict or halt the blood flow. This is frequently used in surgical settings to reduce blood loss and block arterial blood flow, resulting in a treatment that is largely bloodless. Tourniquets help block blood flow in emergency circumstances where there is a risk of significant blood loss, such as acute bleeding or when an artery has been severed.

In typical medical contexts, Latex tourniquets are used to treat patients who have lost too much blood and need to temporarily stop the flow. The presence of a sizable patient pool, rising use across a range of end-use industries, including healthcare and the military, and increased urbanisation are all projected to propel market expansion.

North America took the top spot among regional for Latex Tourniquet Market, accounting for the biggest revenue share. The increase in intestinal-related illnesses and the frequency of traffic accidents in nations like the United States are mostly to blame for the North American market’s revenue rise. Another important element that is anticipated to favourably affect market revenue growth in the area is the rising utilization in urgent applications like surgeries.